144 related articles for article (PubMed ID: 29201766)
21. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
[TBL] [Abstract][Full Text] [Related]
22. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
24. Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy.
Chang YW; Park YM; Oh CH; Oh SJ; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2020 May; 35(3):574-581. PubMed ID: 31830776
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.
Chotivitayatarakorn P; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2839-2843. PubMed ID: 29072432
[TBL] [Abstract][Full Text] [Related]
27. Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.
Zhou YQ; Xu L; Wang BF; Fan XM; Wu JY; Wang CY; Guo CY; Xu XF
Gastroenterol Res Pract; 2012; 2012():405425. PubMed ID: 22550478
[TBL] [Abstract][Full Text] [Related]
28. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(12):4885-90. PubMed ID: 26163609
[TBL] [Abstract][Full Text] [Related]
29. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Ramas M; Donday MG; McNicholl AG; Gisbert JP
Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
[TBL] [Abstract][Full Text] [Related]
31. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
[TBL] [Abstract][Full Text] [Related]
32. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
[TBL] [Abstract][Full Text] [Related]
33. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
Sezikli M; Çetinkaya ZA; Güzelbulut F; Yeşil A; Coşgun S; Kurdaş OÖ
J Clin Pharm Ther; 2012 Jun; 37(3):282-5. PubMed ID: 21740452
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
Baştürk A; Artan R; Yılmaz A
Turk J Gastroenterol; 2016 Sep; 27(5):439-443. PubMed ID: 27782892
[TBL] [Abstract][Full Text] [Related]
35. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
36. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study.
Shavakhi A; Tabesh E; Yaghoutkar A; Hashemi H; Tabesh F; Khodadoostan M; Minakari M; Shavakhi S; Gholamrezaei A
Helicobacter; 2013 Aug; 18(4):280-4. PubMed ID: 23433200
[TBL] [Abstract][Full Text] [Related]
37. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
Sheu BS; Wu JJ; Lo CY; Wu HW; Chen JH; Lin YS; Lin MD
Aliment Pharmacol Ther; 2002 Sep; 16(9):1669-75. PubMed ID: 12197847
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication.
Chunlertlith K; Limpapanasit U; Mairiang P; Vannaprasaht S; Tassaneeyakul W; Sangchan A; Sawadpanich K; Suttichaimongkol T; Pongpit J; Pattarapongsin M
Asian Pac J Cancer Prev; 2017 Apr; 18(4):927-932. PubMed ID: 28545189
[TBL] [Abstract][Full Text] [Related]
39. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
Rakici H; Akdoğan RA; Bedir R; Copur A; Yilmaz A
J Dig Dis; 2014 Sep; 15(9):508-13. PubMed ID: 24980811
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Kato S; Ritsuno H; Ohnuma K; Iinuma K; Sugiyama T; Asaka M
Helicobacter; 1998 Dec; 3(4):278-82. PubMed ID: 9844069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
